Ernst H. Schweizer
Corporate Officer/Principal bij Speedel Pharma AG
Oorsprong van het eerstegraads netwerk van Ernst H. Schweizer
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ernst H. Schweizer via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Hospital/Nursing Management | Corporate Officer/Principal | |
Stratec Medical AGs | Director of Finance/CFO | ||
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
GALENICA AG | Medical Distributors | Director/Board Member | |
University of Lausanne | College/University | Doctorate Degree | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Sentech, Inc.
Sentech, Inc. Electronic Equipment/InstrumentsElectronic Technology Sentech, Inc. engages in the manufacture of position sensing transducers along with supporting signal conditioning and instrumentation. It products include linear variable differential transducers, rotary variable differential transducers, FASTAR sensors, and HydraStar sensors. The company is headquartered in Willow Grove, PA. | Electronic Equipment/Instruments | Director/Board Member | |
Swissmedic
Swissmedic Miscellaneous Commercial ServicesCommercial Services Swissmedic is the national authorisation and supervisory authority for drugs and medical products. It provides clinical laboratory testing services. The company is headquartered in Bern, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Swiss Society of Hypertension | Corporate Officer/Principal | ||
European Society of Hypertension | Treasurer | ||
European Research Council
European Research Council Investment Trusts/Mutual FundsMiscellaneous The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution. | Investment Trusts/Mutual Funds | Treasurer | |
Swiss Society of Nephrology | Corporate Officer/Principal | ||
University of Colorado Health Sciences Center | College/University | Corporate Officer/Principal | |
Institut Straumann AG
Institut Straumann AG Medical/Nursing ServicesHealth Services Institut Straumann AG operates a dentistry group. It engages in the research, development and manufacturing dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions. The company is headquartered in Basel, Switzerland. | Medical/Nursing Services | President | |
Takeda Corp.
Takeda Corp. Pharmaceuticals: MajorHealth Technology Takeda Corp. manufactures and distributes pharmaceutical products. The company is headquartered in Tokyo, Japan | Pharmaceuticals: Major | Corporate Officer/Principal | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
Bristol-Myers Squibb Holdings Ltd.
Bristol-Myers Squibb Holdings Ltd. MiscellaneousMiscellaneous Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Holdings Ltd. is a holding British company. The company is based in Uxbridge, UK. | Miscellaneous | Corporate Officer/Principal | |
The Cancer Drug Development Forum | Director/Board Member | ||
Iqure Pharma, Inc.
Iqure Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Iqure Pharma, Inc. is a biotech company that develops therapeutics for patients and physicians. The company is based in Wilmington, DE. The company was founded by Pawel Zolnierczyk, Henk de Wilde, Peter Schiemann, Anna Rzewuska. Pawel Zolnierczyk has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ymmunobio AG
Ymmunobio AG BiotechnologyHealth Technology Ymmunobio AG is a Swiss preclinical stage oncology biotech company that develops innovative treatments for cancer patients through new classes of antibodies. The company is based in Riehen, Switzerland. The company focuses on high unmet need indications in gastro-intestinal cancers, making extensive progress in developing first-in-class or novel class of antibodies that have the potential to overcome resistance of cancer patients to current available therapies. Ymmunobio's research is based on their deep understanding of immuno-oncology and precision cancer treatments, leveraging their profound knowledge of biologics while selecting the optimal approach to developing transformative therapeutics across cancer indications. The company was founded in 2021 by Katrin Rupalla. The CEO is Peter Schiemann. | Biotechnology | Founder | |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Chairman | |
AMBRX INC | Pharmaceuticals: Major | Chairman | |
ACINO HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO | |
Jones International University | College/University | Masters Business Admin | |
Philipps University of Marburg | College/University | Doctorate Degree | |
4D PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
SUNWAYS AG | Semiconductors | Investor Relations Contact | |
ALTANA AG | Chemicals: Specialty | Public Communications Contact | |
Vensana Capital Management LLC
Vensana Capital Management LLC Investment ManagersFinance Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota. | Investment Managers | Consultant / Advisor | |
Okairos SRL
Okairos SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Okairos SRL is an Italian company that manufactures drugs. The company is based in Rome, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Okairos AG
Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
CRISPR THERAPEUTICS AG | Biotechnology | Chairman | |
Inception 4, Inc.
Inception 4, Inc. Pharmaceuticals: GenericHealth Technology Inception 4, Inc. develops drugs to treat retinal eye disease. It focuses on the development of drugs to treat retinal eye disease, including wet age-related macular degeneration. The firm develops therapeutics for patients with eye diseases. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Generic | Director/Board Member | |
Panmira Pharmaceuticals LLC
Panmira Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Panmira Pharmaceuticals LLC provides drug development programs. It develops pharmaceutical products for inflammatory diseases. The company was founded in September 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Other | Chairman | |
Versant EuroVentures | Chairman | ||
BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
Zwitserland | 24 |
Verenigde Staten | 15 |
Duitsland | 5 |
België | 3 |
Verenigd Koninkrijk | 3 |
Sectoraal
Health Technology | 27 |
Consumer Services | 6 |
Commercial Services | 4 |
Health Services | 3 |
Electronic Technology | 3 |
Operationeel
Director/Board Member | 41 |
Corporate Officer/Principal | 24 |
Chairman | 18 |
Independent Dir/Board Member | 7 |
Director of Finance/CFO | 6 |
Sterkste connecties
Insiders | |
---|---|
Bradley Bolzon | 41 |
Michel Burnier | 13 |
Katrin Rupalla | 13 |
Fritz Kunz | 9 |
Konrad P. Wirz | 4 |
Thomas Littke | 4 |
Harald F. Schäfer | 4 |
Peter Herold | 3 |
Elisabeth Flury | 2 |
Sharon Valdettaro | 1 |
- Beurs
- Insiders
- Ernst H. Schweizer
- Bedrijfsconnecties